Velocity Clinical Research begins European expansion with German site acquisition

Biopharma and CROs to benefit from simplified access to global research sites

Strong execution in Q2 drives full-year 2022 guidance upgrade for Sanofi

Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study

The NTM-001 Phase I clinical study is expected to be completed by the end of 2022

AstraZeneca collaborates with – Indian Society of Nephrology to launch CKD Academy

AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.

Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX

The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.

Dabur launches 'Dabur Himalayan Shilajit'

Funds for R&D in drug discovery and manufacturing :PIB

An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.

Merck updates on Phase 3 Keynote-412 trial in advanced head and neck squamous cell carcinoma

Lupin Diagnostics launches its first reference laboratory in Ranchi

Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies

Glaucoma Research Foundation launches catalyst for a to prevent and cure neurodegeneration

Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's